Mark Jacobson, M.A

2021

In 2021, Mark Jacobson, M.A earned a total compensation of $4.8M as Chief Operating Officer at Axsome Therapeutics, a 103% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$139,060
Option Awards$3,240,166
Salary$409,000
Stock Awards$999,938
Other$6,660
Total$4,794,824

MA received $3.2M in option awards, accounting for 68% of the total pay in 2021.

MA also received $139.1K in non-equity incentive plan, $409K in salary, $999.9K in stock awards and $6.7K in other compensation.

Rankings

In 2021, Mark Jacobson, M.A's compensation ranked 2,749th out of 12,412 executives tracked by ExecPay. In other words, MA earned more than 77.9% of executives.

ClassificationRankingPercentile
All
2,749
out of 12,412
78th
Division
Manufacturing
1,088
out of 5,498
80th
Major group
Chemicals And Allied Products
427
out of 2,374
82nd
Industry group
Drugs
372
out of 2,095
82nd
Industry
Pharmaceutical Preparations
248
out of 1,542
84th

Pay ratio

Mark Jacobson, M.A's Pay$4,794,824
Median Employee's Pay$690,964
Pay Ratio

7

to 1

In 2021, the annual total compensation of Mark Jacobson, M.A was $4,794,824.

The annual total compensation of the median employee at Axsome Therapeutics was $690,964.

The ratio of Mark Jacobson, M.A's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 22, 2022.

MA's colleagues

We found two more compensation records of executives who worked with Mark Jacobson, M.A at Axsome Therapeutics in 2021.

2021

Herriot Tabuteau

Axsome Therapeutics

Chief Executive Officer

2021

Nick Pizzie

Axsome Therapeutics

Chief Financial Officer

News

In-depth

You may also like